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Strategy of HIV‐1 for survival : mutation, adaptation and evolution
Masako Nomaguchi
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SUMMARY
Viruses are the smallest self-replicating organisms in nature. Without a metabolic system of
their own, they survive in their hosts by ably utilizing host’s cellular machinery. To this end,
viruses must continue to mutate and adapt in host’s varying environments. This adaptation
ability is a fundamental property of viruses, closely linking to their survival. Understanding
molecular bases for viral mutation and adaptation would certainly lead to the establishment of
novel strategies against viruses.
HIV‐１ exhibits a narrow host range, and disease-inducing infections are observed only in
human population. The important question “Why and how does HIV‐１ cause disease only in
human?” must be demonstratively solved. To address this issue, HIV‐１infection models for AIDS
are essential. Since valid animal models for this purpose have not been established yet, we now
aim at constructing a novel class of HIV‐１（HIV‐１rmt）that infects experimental macaques and
causes AIDS. Recent studies suggested that HIV‐１ emerged in human population following
repeated species transmission/adaptation to new hosts of different SIVs from various hosts.
Generation of HIV‐１rmt could be considered as an opposite process to HIV‐１ emergence, i.e.,
adapting human-specific HIV‐１to replicate in new host macaques. HIV‐１rmt is a good model virus
to determine functional and structural changes for survival in new hosts. To overcome species
barrier, we modified HIV‐１genome by using two techniques : virus adaption and assisted evolution.
Finally, we successfully constructed HIV‐１rmt clones which can antagonize all intrinsic restriction
factors in macaque cells. Moreover, virological analyses of growth-enhancing mutations appeared
in adaptation processes of the prototype HIV‐１rmt led to the identification of novel genomic
regulatory elements for Vif expression. Our experimental system using HIV‐１rmt and macaque
cells provides pivotal information on molecular bases for species-specific HIV‐１ replication, and
would thus contribute to understanding the HIV‐１pathogenesis.
Key words : HIV‐１, adaptation, macaque-tropic HIV‐１, pathogenesis, replication control
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